October 24-27 2018, Manchester, England. Dr Razis participated in the 15th International Congress of the Society for Melanoma Research with a poster “DESCRIBE III: A Retrospective Analysis of Dabrafenib (D) and/or Dabrafenib Plus Trametinib (D+T) in Patients With Metastatic Melanoma (MM) Participating in the Individual Patient Program (IPP)”.
Leave a Reply